Abintus Bio
Dr. Caron A. Jacobson is the Medical Director, Immune Engineered Cell Therapy Program, Medical Oncology, Dana-Farber Cancer Institute and Assistant Professor, Medicine, Harvard Medical School. Dr. Jacobson specializes in the Use of Chimeric Antigen Receptor T Cell Therapies in Clinical Practice for the treatment of B-cell malignancies. Dr. Jacobson received her medical degree from Columbia University School of Public Health.
This person is not in the org chart
This person is not in any offices
Abintus Bio
Abintus Bio is leading the field of in vivo immune cell reprogramming. Abintus Bio is pursuing products that modulate immune cells from within their native environment to enhance patient access and patient outcomes.